06:20 AM EST, 02/13/2025 (MT Newswires) -- West Pharmaceutical Services ( WST ) reported Q4 adjusted earnings Thursday of $1.82 per diluted share, down from $1.83 a year earlier.

Analysts polled by FactSet expected $1.72.

Revenue for the quarter ended Dec. 31 was $748.8 million compared with $732 million a year earlier.

Analysts surveyed by FactSet expected $740 million.

The company said it expects 2025 adjusted-diluted EPS to range from $6 to $6.20. Analysts surveyed by FactSet expect $7.45. The company expects revenue for the year to be $2.88 billion to $2.91 billion. Analysts polled by FactSet expect $3.04 billion.